Peptide InjectionsAI
High evidence

PT-141

Peptide therapy: benefits, side effects, cost and protocols

7 aa / 1,025.2 g/mol / CID 9941379 / Ac-Nle-cyclo[Asp-Lys], bremelanotide
Nle-D-H-dF-R-W-K

Bremelanotide (PT-141), sold under the brand name Vyleesi, is a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a melanocortin receptor agonist given by subcutaneous injection.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

Lowest listed
$99/mo
FDA status
FDA Approved June 2019 FDA approved as Vyleesi (bremelanotide) for hypoactive sexual desire disorder in premenopausal women. Also compounded.
Evidence
Strong Evidence

PT-141 prices, lowest first

3 listings, $99 to $159 per month.

We may earn a commission at no extra cost to you. Disclosure

PT-141 listed prices by provider
ProviderPer monthLink
PeterMD
PT-141 Injection / 1.75mg as needed
ClinicalRx
$99LowestVisit
Defy Medical
PT-141 (Bremelanotide) / 1.75mg as needed
ClinicalRx
$125Visit
Ageless Rx
PT-141 / as needed
Research Use
$159Visit

Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.

How PT-141 works

Melanocortin-4 receptor agonist that activates sexual arousal pathways in the brain, working differently from PDE5 inhibitors.

Key studies

121 papers on PubMed / 91 human trials

  1. 01

    Safety Profile of Bremelanotide Across the Clinical Development Program

  2. 02

    Clayton AH, Kingsberg SA, Portman D et al

    J Womens Health (Larchmt) / Phase 3

    Bremelanotide shows mostly mild-to-moderate adverse events; nausea most common reason for discontinuation.

  3. 03

    Bremelanotide shows mostly mild-to-moderate adverse events; nausea most common reason for discontinuation

  4. 04

    Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide

  5. 05

    Simon JA, Kingsberg SA, Portman D et al

    J Womens Health (Larchmt) / Phase 3

    Bremelanotide improved sexual desire and reduced distress across multiple demographic and clinical subgroups.

  6. 06

    Bremelanotide improved sexual desire and reduced distress across multiple demographic and clinical subgroups

  7. 07

    Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

  8. 08

    Kingsberg SA, Clayton AH, Portman D et al

    Obstet Gynecol / Obstet Gynecol / Phase 3

    Bremelanotide significantly increased sexual desire and reduced distress in premenopausal women with hypoactive sexual desire disorder.

  9. 09

    Bremelanotide significantly increased sexual desire and reduced distress in premenopausal women with hypoactive sexual desire disorder

  10. 10

    Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

PT-141 compound data

C50H68N14O10
1025.2 g/mol
9941379 ↗
(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-(3-guanidinopropyl)-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid

PT-141 questions

What is PT-141?

PT-141 (Bremelanotide) is a melanocortin peptide approved and available through compounding pharmacies for sexual dysfunction. It works through the central nervous system rather than the vascular system.

How does PT-141 work?

Melanocortin-4 receptor agonist that activates sexual arousal pathways in the brain, working differently from PDE5 inhibitors.

Is PT-141 legal to buy?

PT-141 requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.

Where can I buy PT-141?

PT-141 is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.

What category does PT-141 belong to?

PT-141 is primarily classified as a sexual function & libido peptide. Peptides researched for their effects on sexual function, libido, and reproductive health.

What are the research benefits of PT-141?

PT-141 has been studied for: Sexual function, Libido enhancement, Arousal support. Bremelanotide; available via compounding pharmacies for libido.

PT-141 in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering PT-141?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz